PIK3CD and infection: In rodent models, systemic suppression of the immune response due to chronic use of pan-PI3K inhibitors like LY294002 or wortmannin leads to impaired glucose metabolism, diminished neurogenesis in the hippocampus, and increased risk of infection [137].